Tremfya & Product dose omission issue

16.1%

of users reported Product dose omission issue

60.5%

also reported Severe reaction

55.2%

are women

Severe reaction

60.5%

Hospitalization

28.9%

Disability

7.9%

Medical Intervention

2.6%

Tremfya: general information

10 - 19 years

0.5%

20 - 29 years

6.4%

30 - 39 years

13.2%

40 - 49 years

20.3%

50 - 59 years

27.7%

60 - 69 years

21.3%

70 - 79 years

8.8%

80 - 89 years

1.8%